🟢 Capricor Therapeutics is trading 5% up today as Nasdaq and S&P 500 rise

Capricor Therapeutics is trading 5.17% up at $9.04, in line with a broader market rebound.

• No fresh company-specific announcement explaining the November 6 move was identified.
• The company’s latest listed release announced a November 10 earnings report and corporate update.
• In the supplied market context, the Nasdaq was up 1.54% and the S&P 500 up 0.95%; Friday’s rally followed a stronger-than-expected October jobs report.